<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00151658</url>
  </required_header>
  <id_info>
    <org_study_id>SCANDSTENT</org_study_id>
    <nct_id>NCT00151658</nct_id>
  </id_info>
  <brief_title>Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)</brief_title>
  <official_title>Randomized Multicenter Comparison of Sirolimus Versus Bare Metal Stent Implantation in Complex Coronary Lesions. Acronym: Scand Stent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical and angiographic outcome of
      implantation of stents eluting or not eluting Sirolimus in patients with complex coronary
      artery lesions suitable for percutaneous coronary intervention.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2002</start_date>
  <completion_date>June 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimal lumen diameter</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of restenosis (&gt;50%) at 6 months.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diameter stenosis, late loss and loss index at 6 months MACE: death, myocardial infarction, target lesion revascularisation within 12 months and 24 months</measure>
  </secondary_outcome>
  <enrollment>322</enrollment>
  <condition>Ischaemic Heart Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coronary Drug Eluting Stents for PCI</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Stable, or unstable angina and/or objective signs of myocardial ischaemia Lesions should be
        de novo and located in native vessels with a diameter &gt; 2.25 mm.

        Complex lesions to be included should have at least one of the following characteristics:

          -  Ostial in location (&lt; 5 mm from ostium)

          -  Total occlusions with a length ≥ 15 mm

          -  Bifurcational (side branch &gt; 1.75 mm in diameter)

          -  Angulated (&gt; 45° within lesion)

        Exclusion Criteria:

        Patients:

          -  Other severe disease with an expected survival &lt; 1 year

          -  Other significant cardiac disease

          -  Known allergy against paclitaxel, clopidogrel or stainless steel.

          -  Myocardial infarction within 3 days of the index procedure

          -  Linguistic difficulties needing an interpreter

          -  Renal insufficiency (p-creatinine &gt; 200 micromol/l)

          -  Gastrointestinal bleeding within 1 month

          -  Childbearing potential or pregnancy

          -  Participation in another study

        Lesions:

          -  Unprotected left main disease

          -  Restenosis

          -  Lesions containing visible thrombus

          -  Treatment with other modality than balloon or stent (ablation, brachytherapy,
             ultrasound) in connection with the index procedure

          -  Diffuse coronary disease distal to the treated lesion

          -  Heavily calcification

          -  Lesion located in saphenous vein graft
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Kelbaek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2005</study_first_posted>
  <last_update_submitted>September 12, 2005</last_update_submitted>
  <last_update_submitted_qc>September 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2005</last_update_posted>
  <keyword>Coronary complex lesions</keyword>
  <keyword>Restenosis</keyword>
  <keyword>Drug eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sirolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

